Works matching IS 20726694 AND DT 2018 AND VI 10 AND IP 12


Results: 65
    1
    2
    3

    NK Cell-Based Glioblastoma Immunotherapy.

    Published in:
    Cancers, 2018, v. 10, n. 12, p. 522, doi. 10.3390/cancers10120522
    By:
    • Golán, Irene;
    • Rodríguez de la Fuente, Laura;
    • Costoya, Jose A.
    Publication type:
    Article
    4
    5
    6
    7

    EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma.

    Published in:
    Cancers, 2018, v. 10, n. 12, p. 519, doi. 10.3390/cancers10120519
    By:
    • Offenhäuser, Carolin;
    • Al-Ejeh, Fares;
    • Puttick, Simon;
    • Ensbey, Kathleen S.;
    • Bruce, Zara C.;
    • Jamieson, Paul R.;
    • Smith, Fiona M.;
    • Stringer, Brett W.;
    • Carrington, Benjamin;
    • Fuchs, Adrian V.;
    • Bell, Craig A.;
    • Jeffree, Rosalind;
    • Rose, Stephen;
    • Thurecht, Kristofer J.;
    • Boyd, Andrew W.;
    • Day, Bryan W.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC.

    Published in:
    Cancers, 2018, v. 10, n. 12, p. 486, doi. 10.3390/cancers10120486
    By:
    • Schneider, Marc A.;
    • Muley, Thomas;
    • Weber, Rebecca;
    • Wessels, Sabine;
    • Thomas, Michael;
    • Herth, Felix J. F.;
    • Kahn, Nicolas C.;
    • Eberhardt, Ralf;
    • Winter, Hauke;
    • Heussel, Gudula;
    • Warth, Arne;
    • Herold-Mende, Christel;
    • Meister, Michael
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50